Article info
Cancer genetics
Short report
Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation
- Correspondence to Professor D Gareth Evans, Division of Evolution and Genomic Science, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester M13 9WL, UK; gareth.evans{at}mft.nhs.uk
Citation
Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation
Publication history
- Received September 25, 2022
- Accepted December 22, 2022
- First published January 4, 2023.
Online issue publication
October 18, 2023
Article Versions
- Previous version (18 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.